Senseonics (NASDAQ:SENS) Raised to Hold at Wall Street Zen

Key Points

• Wall Street Zen upgraded Senseonics from Sell to Hold. Analyst sentiment is mixed overall, with MarketBeat reporting a consensus Hold rating and an average price target of $14.40.
• Several brokerages raised their price targets: Mizuho to $20, TD Cowen to $17, and Barclays to $11; HC Wainwright maintained Buy with a $14 target.
• Senseonics reported quarterly revenue of $19.56 million, while its loss per share of $0.50 slightly missed the $0.49 consensus estimate. Shares were reported up 5.4%.

Senseonics (NASDAQ:SENS - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.

A number of other brokerages have also recently commented on SENS. Mizuho raised their target price on Senseonics from $18.00 to $20.00 and gave the company an "outperform" rating in a report on Tuesday. TD Cowen boosted their price target on shares of Senseonics from $15.00 to $17.00 and gave the stock a "buy" rating in a research note on Tuesday. Barclays increased their price target on shares of Senseonics from $10.00 to $11.00 and gave the stock an "equal weight" rating in a research report on Tuesday. Weiss Ratings raised shares of Senseonics from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Wednesday, November 4th. Finally, HC Wainwright reissued a "buy" rating and issued a $14.00 price objective on shares of Senseonics in a research note on Tuesday. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $14.40.

Senseonics Trading Up 5.4%

Shares of NASDAQ SENS opened at $10.58 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 5.92 and a quick ratio of 6.40. The business's 50 day moving average is $9.17 and its two-hundred day moving average is $7.33. Senseonics has a 52-week low of $4.79 and a 52-week high of $13.98.

Senseonics (NASDAQ:SENS - Get Free Report) last released its quarterly earnings results on Monday, November 9th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.01). Senseonics had a negative return on equity of 186.11% and a negative net margin of 204.01%. The firm had revenue of $19.56 million for the quarter. As a group, equities research analysts predict that Senseonics will post -2.20 EPS for the current fiscal year.

Insider Buying and Selling at Senseonics

In related news, Director Douglas Roeder acquired 13,953 shares of the business's stock in a transaction dated Wednesday, August 19th. The shares were acquired at an average price of $8.98 per share, with a total value of $125,297.94. Following the completion of the transaction, the director owned 171,191 shares of the company's stock, valued at $1,537,295.18. The trade was a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 4.70% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. purchased a new stake in Senseonics during the 2nd quarter worth about $15,867,000. Masters Capital Management LLC boosted its stake in shares of Senseonics by 100.0% in the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company's stock valued at $3,330,000 after buying an additional 250,002 shares during the period. Bank of America Corp DE purchased a new position in shares of Senseonics in the 2nd quarter valued at about $2,241,000. Empowered Funds LLC acquired a new position in shares of Senseonics during the third quarter worth about $621,000. Finally, Readystate Asset Management LP acquired a new position in shares of Senseonics during the second quarter worth about $574,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics News Summary

Investors following SENS have been watching these news items:

• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and $14 price target. It also raised some longer-term EPS estimates, including for FY2026 and FY2028–FY2030, signaling some improvement in its longer-range outlook. HC Wainwright rating HC Wainwright earnings estimate revisions
• Neutral Sentiment: Stifel Nicolaus assigned a Hold rating, while Raymond James upgraded SENS to Market Perform. These stances are more cautious than a Buy recommendation but do not signal an outright bearish view. Stifel rating Raymond James rating
• Negative Sentiment: HC Wainwright lowered several 2026–2027 quarterly EPS forecasts and its FY2027 estimate, reflecting expectations of larger losses in those periods. This tempers the positive longer-term revisions. HC Wainwright earnings estimate revisions

About Senseonics

Senseonics Holdings, Inc. develops continuous glucose monitoring (CGM) technology for people with diabetes. Its Eversense systems use a small sensor implanted under the skin to measure glucose levels, an external wearable transmitter to send readings, and a mobile app to display data and provide alerts. The company’s product line includes implantable CGM systems designed for extended wear, including the Eversense 365 system, which is designed to last up to one year. Unlike many CGM products that use sensors replaced more frequently, Eversense sensors are inserted and removed by a healthcare professional.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.